Definium Therapeutics Inc (DFTX)
EBITDA Growth
-247.93%
TTM · Period ending:
DFTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-247.93%period ending
Latest reported-247.93%period ending
DFTX TTM EBITDA YoY % (28.37% → -247.93%)
Year-over-year change
High-resolution chart · PNG
DFTX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -247.9313% | |
| -255.1045% | |
| -82.0577% | |
| -95.7244% | |
| 1.0851% | |
| 48.4981% | |
| -1.3248% | |
| -13.5311% | |
| -37.0541% | |
| -102.9953% | |
| -71.8431% | |
| -8.9852% | |
| -6.3058% | |
| 37.6206% | |
| 41.5337% | |
| 24.6464% | |
| 15.5122% | |
| -130.4179% | |
| -182.1939% | |
| -366.607% | |
| -581.4834% | |
| -589.4588% | |
| -822.2057% | |
| -1,642.665% | |
| -520.5004% | |
| -90.6471% | |
| 50.8513% | |
| 26.2204% | |
| 22.8573% | |
| 28.3676% |